1. Home
  2. ABP vs ZENV Comparison

ABP vs ZENV Comparison

Compare ABP & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • ZENV
  • Stock Information
  • Founded
  • ABP 2004
  • ZENV 2005
  • Country
  • ABP United States
  • ZENV Brazil
  • Employees
  • ABP N/A
  • ZENV N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • ZENV Computer Software: Prepackaged Software
  • Sector
  • ABP Health Care
  • ZENV Technology
  • Exchange
  • ABP Nasdaq
  • ZENV Nasdaq
  • Market Cap
  • ABP 78.8M
  • ZENV 63.3M
  • IPO Year
  • ABP N/A
  • ZENV 2021
  • Fundamental
  • Price
  • ABP $1.10
  • ZENV $1.76
  • Analyst Decision
  • ABP
  • ZENV
  • Analyst Count
  • ABP 0
  • ZENV 0
  • Target Price
  • ABP N/A
  • ZENV N/A
  • AVG Volume (30 Days)
  • ABP 47.0K
  • ZENV 76.2K
  • Earning Date
  • ABP 04-03-2025
  • ZENV 11-18-2024
  • Dividend Yield
  • ABP N/A
  • ZENV N/A
  • EPS Growth
  • ABP N/A
  • ZENV N/A
  • EPS
  • ABP N/A
  • ZENV N/A
  • Revenue
  • ABP $122,000.00
  • ZENV $173,594,726.00
  • Revenue This Year
  • ABP N/A
  • ZENV $25.56
  • Revenue Next Year
  • ABP N/A
  • ZENV $6.02
  • P/E Ratio
  • ABP N/A
  • ZENV N/A
  • Revenue Growth
  • ABP N/A
  • ZENV 23.49
  • 52 Week Low
  • ABP $1.09
  • ZENV $1.00
  • 52 Week High
  • ABP $13.00
  • ZENV $3.88
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • ZENV 62.77
  • Support Level
  • ABP N/A
  • ZENV $1.61
  • Resistance Level
  • ABP N/A
  • ZENV $1.76
  • Average True Range (ATR)
  • ABP 0.00
  • ZENV 0.12
  • MACD
  • ABP 0.00
  • ZENV 0.01
  • Stochastic Oscillator
  • ABP 0.00
  • ZENV 66.67

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

About ZENV Zenvia Inc.

Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.

Share on Social Networks: